Oqal

Oqal is Saudi Arabia’s largest angel investor network, bringing together experienced angels to fund early-stage technology and healthcare startups across pre-seed, seed, and Series A with checks in the $250k to $1M range. AI is a stated focus, and the network’s scale and Riyadh-based gravity make it one of the most institutionalized angel platforms in the GCC. The structure matters: Oqal is a syndicate of individuals operating under a network framework rather than a fund with a single investment committee, so engagement requires understanding which specific angels lead and care about your category. The right founder for Oqal is a Saudi or Saudi-based operator, ideally with one or two reference customers, building a digital health, healthcare AI, or tech-enabled care business with credible Saudi-market wedge and either GCC or wider MENA expansion logic. The wrong founder is a deep medtech or therapeutics team needing scientific syndicate construction, a non-Saudi founder without a Saudi-market thesis, or a Series A-plus company looking for institutional lead. Intro paths run through Riyadh’s tight technology ecosystem including Monsha’at programs, the King Saud University and KFUPM operator networks, and the broader MISK and KAUST affiliated communities. Frequent co-investors and follow-on partners include Wa’ed Ventures, STV, Impact46, Hala Ventures, and Sanabil 500 MENA. Direct application through Oqal’s pitch nights is the standard entry; warm intros from active members are a meaningful accelerator. In the pitch, lead with the Saudi-market wedge, real customer evidence including any anchor pilots with major private health groups or government contracts, and a credible Vision 2030 alignment narrative. Be specific about MOH and SFDA pathways where relevant, NPHIES interoperability if applicable, and Saudization implications for hiring. Show that you understand the difference between Riyadh, Jeddah, and Eastern Province health markets and the demographics of each. Caveats include the syndicate dynamics: diligence speed varies by which angels lead, term sheets are negotiated rather than templated, and post-investment support depends entirely on which specific angels engage. Founders who research the active members and target a thesis-aligned subset get a much better experience. For Saudi healthcare entrepreneurs, Oqal is the most institutionalized angel option with genuine ecosystem depth, and the right complement to a follow-on Saudi-focused VC.